A detailed history of Sovereign Financial Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sovereign Financial Group, Inc. holds 4,898 shares of MRK stock, worth $537,653. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,898
Previous 4,905 0.14%
Holding current value
$537,653
Previous $647,000 6.34%
% of portfolio
0.15%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$123.8 - $132.96 $866 - $930
-7 Reduced 0.14%
4,898 $606,000
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $61,036 - $71,121
539 Added 12.35%
4,905 $647,000
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $81,546 - $88,742
-814 Reduced 15.71%
4,366 $475,000
Q3 2023

Nov 03, 2023

SELL
$102.95 - $114.33 $91,625 - $101,753
-890 Reduced 14.66%
5,180 $533,000
Q2 2023

Jul 31, 2023

BUY
$108.61 - $118.38 $19,441 - $21,190
179 Added 3.04%
6,070 $700,000
Q1 2023

May 04, 2023

BUY
$102.94 - $114.86 $617 - $689
6 Added 0.1%
5,891 $626,000
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $187,471 - $240,363
2,144 Added 57.31%
5,885 $652,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $16,821 - $18,897
-199 Reduced 5.05%
3,741 $322,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $7,347 - $8,328
-88 Reduced 2.18%
3,940 $359,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $69,613 - $78,032
947 Added 30.74%
4,028 $330,000
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $222,694 - $278,953
3,081 New
3,081 $236,000
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $230,092 - $253,044
-3,210 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $50,887 - $59,940
739 Added 29.91%
3,210 $247,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $177,343 - $196,815
2,471 New
2,471 $202,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sovereign Financial Group, Inc. Portfolio

Follow Sovereign Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sovereign Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sovereign Financial Group, Inc. with notifications on news.